<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Salofalk preparations; Mesalazine" /><meta name="IX" content="Salofalk preparations; Mesalazine" /><title>Salofalk®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP501-salofalk.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP501-salofalk.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP501-salofalk.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 08 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP271-gastro-intestinal-system.htm">1 Gastro-intestinal system</a> &gt; <a href="PHP478-chronic-bowel-disorders.htm">1.5 Chronic bowel disorders</a> &gt; <a href="PHP487-aminosalicylates.htm">1.5.1 Aminosalicylates</a> &gt; <a href="PHP493-mesalazine.htm">MESALAZINE</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP491-balsalazide-sodium.htm" title="Previous: BALSALAZIDE SODIUM">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP502-olsalazine-sodium.htm" title="Next: OLSALAZINE SODIUM">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a388021.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mesalamine</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Gastrointestinal Drugs 56:00 &gt; Anti-inflammatory Agents 56:36</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/16887-a.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Mesalazine</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: M &gt; Interactions of Mesalazine</p></div></li></ul><ul><li><h3>British National Formulary (10)</h3></li><li><a href="PHP479-inflammatory-bowel-disease.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Inflammatory bowel disease</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders</p></div></li><li><a href="PHP487-aminosalicylates.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">1.5.1 Aminosalicylates</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders</p></div></li><li><a href="PHP493-mesalazine.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">MESALAZINE</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders &gt; 1.5.1 Aminosalicylates</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22mesalazine%22%22mesalazine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (10)</a></li></ul><ul><li><h3>BNF for Children (9)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP11193-inflammatory-bowel-disease.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Inflammatory bowel disease</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP11198-aminosalicylates.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">1.5.1 Aminosalicylates</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP11205-mesalazine.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">MESALAZINE</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders &gt; 1.5.1 Aminosalicylates</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22mesalazine%22%22mesalazine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (9)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK-TD-c316-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Balsalazide</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; B</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0012s0133.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mesalamine</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; M</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/16887-a.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mesalazine</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Gastrointestinal Drugs &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/4951-n.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Sulfasalazine</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Gastrointestinal Drugs &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/05904.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mesalamine</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; M &gt; ME</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-M36.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mesalamine</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; M</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E6E3E0R0D802.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Mesalazine</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; M</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c238.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mesalazine</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; M</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>MESALAZINE</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int930-mesalazine.htm">Mesalazine</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">treatment of mild to moderate ulcerative colitis and maintenance of remission; see also under preparations</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">see <a title="target-block: aminosalicylates cautions" href="PHP487-aminosalicylates.htm#PHP488">notes above</a>; elderly; <strong>interactions:</strong> Appendix 1 (aminosalicylates)</p></div> <div class="cG"><div class="cE"><h3 class="cT">Blood disorders</h3> <p class="cT">See <a title="target-block: Aminosalicylates blood disorders" href="PHP487-aminosalicylates.htm#PHP489">recommendation above</a></p></div></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Contra-indications </h2> <p class="cT">see <a title="target-block: Aminosalicylates contra-indications" href="PHP487-aminosalicylates.htm#PHP490">notes above</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">avoid in severe impairment</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">use with caution; avoid if eGFR less than 20 mL/minute/1.73 m<sup>2</sup></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">negligible quantities cross placenta</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">diarrhoea reported but negligible amounts detected in breast milk; monitor infant for diarrhoea</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">see notes above</p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p>See under preparations, below</p></li>  </ul><div class="cG"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">The delivery characteristics of oral mesalazine preparations may vary; these preparations should not be considered interchangeable</p></div></div></div></div> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="PHP494-asacol.htm#PHP494-asacol" title="Asacol®">Asacol®</a></li><li><a href="PHP495-asacol-mr.htm#PHP495-asacol-mr" title="Asacol® MR">Asacol® MR</a></li><li><a href="PHP496-ipocol.htm#PHP496-ipocol" title="Ipocol®">Ipocol®</a></li><li><a href="PHP497-mesren-mr.htm#PHP497-mesren-mr" title="Mesren® MR">Mesren® MR</a></li><li><a href="PHP498-mezavant-xl.htm#PHP498-mezavant-xl" title="Mezavant® XL">Mezavant® XL</a></li><li><a href="PHP499-octasa.htm#PHP499-octasa" title="Octasa®">Octasa®</a></li><li><a href="PHP500-pentasa.htm#PHP500-pentasa" title="Pentasa®">Pentasa®</a></li></ul><div id="PHP501-salofalk" style="margin: 0 0 0 20px;"><h1 class="title">Salofalk® <span>(<a href="PHP10005-index-of-manufacturers.htm#PHP10122">Dr Falk</a>)</span><span> <img src="images/pom_l.png" alt="Prescription only medicine" /></span></h1><div class="cU"><p><strong>Tablets</strong>, e/c, yellow, mesalazine 250 mg, net price 100-tab pack = £16.19; 500 mg, 100-tab pack = £32.38. Label: 5, 25, counselling, blood disorder symptoms (see recommendation <a title="BNF:target-block: Aminosalicylates blood disorders" href="PHP487-aminosalicylates.htm#PHP489">above</a>)</p><p class="cR"><strong>Dose </strong>acute attack, 0.5–1 g 3 times daily; maintenance, 500 mg three times daily; <span class="cP">child</span> 6–18 years see <a title="BNFC:preparation: Salofalk®" href="http://www.medicinescomplete.com/mc/bnfc/current/PHP11205.htm#PHP11211"><em>BNF for Children</em></a></p></div><div class="cU"><p><strong>Granules</strong>, m/r, grey, e/c, vanilla-flavoured, mesalazine 500 mg/sachet, net price 100-sachet pack = £28.74; 1 g/sachet, 50-sachet pack = £28.74; 1.5 g/sachet, 60-sachet pack = £48.85; 3 g/sachet, 60-sachet pack = £97.70. Label: 25, counselling, administration, see dose, blood disorder symptoms (see recommendation <a title="BNF:target-block: Aminosalicylates blood disorders" href="PHP487-aminosalicylates.htm#PHP489">above</a>)</p><p class="cR"><span class="cAD">Excipients </span>include aspartame (<a title="sub-section: Foods for special diets" href="PHP6075-foods-for-special-diets.htm">section 9.4.1</a>)</p><p class="cR"><strong>Dose </strong>acute attack, 1.5–3 g once daily (preferably in the morning) <em>or</em> 0.5–1 g 3 times daily; maintenance, 500 mg 3 times daily; <span class="cP">child</span> 6–18 years see <a title="BNFC:preparation: Salofalk®" href="http://www.medicinescomplete.com/mc/bnfc/current/PHP11205.htm#PHP11211"><em>BNF for Children</em></a></p><div class="cG"><div class="cE"><h3 class="cT">Counselling</h3> <p class="cT">granules should be placed on tongue and washed down with water without chewing</p></div></div><div class="cG"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">Preparations that lower stool pH (e.g. lactulose) may prevent release of mesalazine</p></div></div></div><div class="cU"><p><strong>Suppositories</strong>, mesalazine 500 mg. Net price 30-suppos pack = £14.81. Counselling, blood disorder symptoms (see recommendation <a title="BNF:target-block: Aminosalicylates blood disorders" href="PHP487-aminosalicylates.htm#PHP489">above</a>)</p><p class="cR"><strong>Dose </strong><span class="cP">adult</span> and <span class="cP">child</span> over 15 years, acute attack, <span class="cK">by rectum</span>, 0.5–1 g 2–3 times daily adjusted according to response; <span class="cP">child</span> 12–15 years see <a title="BNFC:preparation: Salofalk®" href="http://www.medicinescomplete.com/mc/bnfc/current/PHP11205.htm#PHP11211"><em>BNF for Children</em></a></p></div><div class="cU"><p><strong>Enema</strong>, mesalazine 2 g in 59-mL pack. Net price 7 enemas = £29.92. Counselling, blood disorder symptoms (see recommendation <a title="BNF:target-block: Aminosalicylates blood disorders" href="PHP487-aminosalicylates.htm#PHP489">above</a>)</p><p class="cR"><strong>Dose </strong>acute attack <em>or</em> maintenance, <span class="cK">by rectum</span>, 2 g daily at bedtime; <span class="cP">child</span> 12–18 years see <a title="BNFC:preparation: Salofalk®" href="http://www.medicinescomplete.com/mc/bnfc/current/PHP11205.htm#PHP11211"><em>BNF for Children</em></a></p></div><div class="cU"><p><strong>Rectal foam</strong>, mesalazine 1 g/metered application, net price 14-application canister with disposable applicators and plastic bags = £30.17. Counselling, blood disorder symptoms (see recommendation <a title="BNF:target-block: Aminosalicylates blood disorders" href="PHP487-aminosalicylates.htm#PHP489">above</a>)</p><p class="cR"><span class="cAD">Excipients </span>include cetostearyl alcohol, disodium edetate, polysorbate 60, propylene glycol, sodium metabisulfite</p><p class="cR"><strong>Dose </strong>mild ulcerative colitis affecting sigmoid colon and rectum, <span class="cP">adult</span> and <span class="cP">child</span> over 12 years, 2 metered applications (mesalazine 2 g) into the rectum at bedtime or in 2 divided doses</p></div></div></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP491-balsalazide-sodium.htm">Previous: BALSALAZIDE SODIUM</a> | <a class="top" href="PHP501-salofalk.htm#">Top</a> | <a accesskey="]" href="PHP502-olsalazine-sodium.htm">Next: OLSALAZINE SODIUM</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>